ethyl 2-(4-(9,10-dioxo-9,10-dihydroanthracen-1-yl)-1H-pyrazol-1-yl)propanoate

ID: ALA4442031

PubChem CID: 154697563

Max Phase: Preclinical

Molecular Formula: C22H18N2O4

Molecular Weight: 374.40

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)C(C)n1cc(-c2cccc3c2C(=O)c2ccccc2C3=O)cn1

Standard InChI:  InChI=1S/C22H18N2O4/c1-3-28-22(27)13(2)24-12-14(11-23-24)15-9-6-10-18-19(15)21(26)17-8-5-4-7-16(17)20(18)25/h4-13H,3H2,1-2H3

Standard InChI Key:  YFKGOBKLSOTNRJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   31.0560  -13.6693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0548  -14.4889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7629  -14.8978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7611  -13.2605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4697  -13.6657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4686  -14.4864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1747  -14.8954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1771  -13.2542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8878  -13.6677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8861  -14.4848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5917  -14.8929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2995  -14.4852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2972  -13.6651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5910  -13.2606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1771  -12.4370    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.1742  -15.7126    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.5891  -12.4434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2439  -11.9599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9900  -11.1827    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.1723  -11.1853    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.9217  -11.9630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4112  -10.4825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2283  -10.4971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0154   -9.7675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6241  -11.2120    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.6495   -9.7968    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.4412  -11.2267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8370  -11.9416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5  8  1  0
  6  7  1  0
  7 10  1  0
  9  8  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  8 15  2  0
  7 16  2  0
 14 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 17  1  0
 19 22  1  0
 22 23  1  0
 22 24  1  0
 23 25  1  0
 23 26  2  0
 25 27  1  0
 27 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4442031

    ---

Associated Targets(Human)

PDK4 Tchem Pyruvate dehydrogenase kinase isoform 4 (177 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 374.40Molecular Weight (Monoisotopic): 374.1267AlogP: 3.45#Rotatable Bonds: 4
Polar Surface Area: 78.26Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.97CX LogP: 3.54CX LogD: 3.54
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.51Np Likeness Score: -0.44

References

1. Lee D, Pagire HS, Pagire SH, Bae EJ, Dighe M, Kim M, Lee KM, Jang YK, Jaladi AK, Jung KY, Yoo EK, Gim HE, Lee S, Choi WI, Chi YI, Song JS, Bae MA, Jeon YH, Lee GH, Liu KH, Lee T, Park S, Jeon JH, Lee IK, Ahn JH..  (2019)  Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases.,  62  (2): [PMID:30623649] [10.1021/acs.jmedchem.8b01168]

Source